Redefining Biologics Workflows with AI-Designed Binding Proteins


Next-gen BLI probes are improving data quality, speed, and discovery outcomes


Recombinant binding proteins continue to push biologics forward—but as workflows expand into ADCs, bi-specifics, nanobodies, and more, traditional tools are showing their limitations.

This whitepaper explores how AI-designed binding proteins are reshaping assay development and antibody discovery—showcasing the NovoBody™ His XT probe from GatorBio, a new class of probe built specifically for complex Biolayer Interferometry (BLI) assays like Fc receptors and screening from cell free media.

Discover how the next-generation NovoBody™ His XT probe can deliver:

  • Up to 58% less baseline drift
  • Up to 4× higher signal response
  • Reliable detection from pM to μM affinities
  • 10× faster loading with lower sample consumption
  • Regeneration across 10+ cycles with >90% capacity retention

From early discovery to characterization, see how this novel BLI approach can support:

  • Kinetic analysis and affinity measurements
  • Epitope binning (full 12×12 screens in ~4 hours)
  • Quantitation assays using real-time binding
  • Fc receptor interaction studies
  • Cell-free screening workflows (no purification required)

Download the whitepaper and learn how traditional antibody-based probes are being replaced by compact, monovalent, AI-designed scaffolds for more efficient discovery and screening workflows.

DOWNLOAD THIS WHITEPAPER TO LEARN MORE

Become a member and enjoy exclusive benefits

Create an account now for exclusive benefits, personalized recommendations, and seamless order tracking. Elevate your lab experience today!